Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | LTA4H | P09960 | 1/20 | 0.39 |
| ▸ | HRH2 | P25021 | 2/20 | 0.38 |
| ▸ | HRH1 | P35367 | 2/20 | 0.38 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28691369 | 0.98 | CXCR4 (0.44) | CXCR4MEN1KMT2ASIGMAR1POLB | |
| SCHEMBL14141932 | 0.96 | MEN1 (0.47) | CXCR4MEN1KMT2ASIGMAR1POLB | |
| SCHEMBL12442021 | 0.94 | MEN1 (0.46) | CXCR4MEN1KMT2ASIGMAR1POLB | |
| SCHEMBL20333191 | 0.92 | CXCR4 (0.44) | CXCR4MEN1KMT2ASIGMAR1HRH2 | |
| SCHEMBL2632039 | 0.92 | CXCR4 (0.47) | CXCR4MEN1KMT2ASIGMAR1POLB | |
| Hydrochloric Acid SCHEMBL28709630 | 0.91 | CXCR4 (0.56) | CXCR4MEN1KMT2ASIGMAR1HRH2 | |
| SCHEMBL10034551 | 0.90 | CXCR4 (0.48) | CXCR4SIGMAR1HRH2HRH1HRH3 | |
| SCHEMBL21348463 | 0.88 | CXCR4 (0.44) | CXCR4MEN1KMT2ASIGMAR1POLB | |
| SCHEMBL10926853 | 0.88 | CXCR4 (0.52) | CXCR4SIGMAR1HRH2HRH1 | |
| SCHEMBL8392367 | 0.88 | SIGMAR1 (0.37) | CXCR4MEN1KMT2ASIGMAR1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 244 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116764689-A | Method for stripping carbamate from ion exchange resin | 埃克-泰克股份有限公司 | 2023-09-19 | — | — | CN | claimed |
| US-10898891-B2 | Process for stripping carbamate from ion exchange resin | ECO-TEC LTD. (CA) | 2021-01-26 | — | — | US | claimed |
| US-20190009268-A1 | Process for Stripping Carbamate from Ion Exchange Resin | CERBERUS BUSINESS FINANCE AGENCY, LLC, AS COLLATERAL AGENT | 2019-01-10 | — | — | US | claimed |
| EP-3337612-A1 | PROCESS FOR STRIPPING CARBAMATE FROM ION EXCHANGE RESIN | Eco-Tec Ltd. (CA) | 2018-06-27 | — | — | EP | claimed |
| US-20140273458-A1 | Chemical Mechanical Planarization for Tungsten-Containing Substrates | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2014-09-18 | — | — | US | claimed |
| EP-2779217-A2 | Chemical mechanical planarization for tungsten-containing substrates | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2014-09-17 | — | — | EP | claimed |
| CN-104046246-A | Chemical Mechanical Planarization for Tungsten-Containing Substrates | AIR PROD & CHEM | 2014-09-17 | — | — | CN | claimed |
| US-8771403-B2 | Method and system for capturing carbon dioxide and/or sulfur dioxide from gas stream | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-07-08 | — | — | US | claimed |
| WO-2012030630-A1 | METHOD AND SYSTEM FOR CAPTURING CARBON DIOXIDE AND/OR SULFUR DIOXIDE FROM GAS STREAM | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-03-08 | — | — | WO | claimed |
| EP-1831206-B1 | N-SUBSTITUTED BENZIMIDAZOLYL C-KIT INHIBITORS AND COMBINATORIAL BENZIMIDAZOLE LIBRARY | OSI PHARM INC (US) | 2011-08-24 | — | — | EP | claimed |
| US-20110124195-A1 | Chemical Mechanical Polishing Composition Containing Polysilicon Polish Finisher | TECHNO SEMICHEM CO., LTD. (KR) | 2011-05-26 | — | — | US | claimed |
| JP-2008521903-A | — | — | 2008-06-26 | — | — | JP | claimed |
| EP-1831206-A2 | N-SUBSTITUTED BENZIMIDAZOLYL C-KIT INHIBITORS AND COMBINATORIAL BENZIMIDAZOLE LIBRARY | OSI Pharmaceuticals, Inc. (US) | 2007-09-12 | — | — | EP | claimed |
| WO-2006060381-A2 | N-SUBSTITUTED BENZIMIDAZOLYL C-KIT INHIBITORS AND COMBINATORIAL BENZIMIDAZOLE LIBRARY | OSI PHARMACEUTICALS, INC. (US) | 2006-06-08 | — | — | WO | claimed |
| US-20060116402-A1 | N-substituted benzimidazolyl c-Kit inhibitors and combinatorial benzimidazole library | OSI PHARMACEUTICALS, INC. | 2006-06-01 | — | — | US | claimed |
| WO-2025151605-A1 | IONIZABLE AMPHIPHILIC JANUS DENDRIMERS, DELIVERY SYSTEMS COMPRISING THEREOF, AND METHODS OF USE THEREOF | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2025-07-17 | — | — | WO | disclosed |
| WO-2025038627-A2 | PENTAERYTHRITOL-BASED IONIZABLE AMPHIPHILIC JANUS DENDRIMERS, DELIVERY SYSTEMS COMPRISING THEREOF, AND METHODS OF USE THEREOF | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2025-02-20 | — | — | WO | disclosed |
| US-5296445-A | Quinoline dyes | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1994-03-22 | — | — | US | disclosed |
| EP-0527051-A1 | Quinophthalone dyes, ink composition and transfer sheet containing them | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1993-02-10 | — | — | EP | disclosed |
| EP-0049683-A2 | Imidazo-rifamycines, process for their preparation, pharmaceutical preparations containing them and their use | CIBA-GEIGY AG (CH) | 1982-04-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060116402-A1 | N-substituted benzimidazolyl c-Kit inhibitors and combinatorial benzimidazole library | KIT, CHUK, TNNI3K | CXCR4 1901/4885MEN1 791/4885KMT2A 974/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.